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Abstract 
Given the advantage and trend of the clinically relevant optimization in radiotherapy, a novel 
optimization method using objective function based on tumor control probability (TCP) and normal tissue 
complication probability (NTCP) was proposed, which can improve global optimization capacity of 
simulated annealing optimization algorithm (SA) by increasing poor solutions acceptance rate. The 
effectiveness and superiority of the new method was verified in prostate cancer cases. Experimental 
results show that the proposed radiotherapy optimization method, not only can improve DVH curve of 
organs at risk, reduce the NTCP, and improve the therapeutic gain ration, but also can decrease hot spots 
and gain better dose distribution uniformity of the target. 
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1. Introduction 
Intensity-modulated radiation therapy (IMRT) is an advanced mode of high-precision 
radiotherapy that uses computer-controlled linear accelerators to deliver precise radiation doses 
to a malignant tumor or specific areas within the tumor. IMRT allows for the radiation dose to 
conform more precisely to the three-dimensional (3-D) shape of the tumor by modulating or 
controlling the intensity of the radiation beam in multiple small volumes. IMRT also allows higher 
radiation doses to be focused to regions within the tumor while minimizing the dose to 
surrounding normal critical structures. 
Objective function is an important index for the optimization and evaluation of treatment 
planning. It is not only a tool to evaluate the treatment plan, but also the connection between the 
input parameters and the output dose distribution. Now Objective functions used in radiotherapy 
optimization are based either on physical factors or on biological formulations [1]. The former 
employs a physical quadratic dose-based objective function, which, via a combination of 
weighted terms, penalizes differentially violations of the various dose and/or dose-volume 
constraints specified with respect to the organs and the targets considered in the optimization 
process [2-4]. However, this type of physics-based approach is unable, to sufficiently take into 
account the nonlinear response of tumors or normal structures to irradiation, especially with 
arbitrary inhomogeneous dose distribution [5]. In order to be meaningful the optimization 
process must be “clinically relevant’’ instead of being simply dose distribution oriented [6]. It is 
desirable to employ the biological objective function into the inverse planning, as well as 
balancing the various normal tissue complication probabilities (NTCP) with respect to each other 
and with respect to the tumor control probability (TCP).  
Mainly three kinds of biological criteria can be applied: (generalized) equivalent uniform 
dose ((g)EUD), tumor control probability (TCP), and normal tissue complication probability 
(NTCP)[7].  
The merits of including the gEUD concept into an objective function have been widely 
investigated [5, 8-13]. Based on a volume parameter a, (g)EUD corresponds, for a given non-
uniform dose distribution, to the uniform dose that induces the same biological effect. And the 
NTCP biological criteria has been used in inverse treatment planning optimization [3, 6, 14-
16]and incorporated into some commercial treatment planning software [14, 17]. The advantage 
of the TCP criteria, also, was investigated [6, 18-19]. Nevertheless the gEUD model cannot 
directly quantify the NTCP and TCP. In contrast, both NTCP and TCP models are more 
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clinically relevant. If all constraints of the inverse planning objective function are satisfied, the 
NTCP-based and TCP-based treatment plan should be directly implemented, and there is no 
need to further optimize. 
Based on Mohan et al’s research, we did some researches to improve optimized 
quality. Mohan et al (1992) used a single score, mixing TCP with NTCP criteria to reduce 
normal tissue complication rates and increase tumor control. Because both NTCP and TCP 
criterias are sigmoidal functions of dose distributions [20-24], and they are thus inherently 
nonlinear and non-convex in terms of fluence elements in fluence map optimization (FMO).The 
fast simulated annealing approach was applied to solve this non-convex optimization problem. 
In their work, calculated TCP was defined as the TCP sub-score, without paying additional 
penalty, while piecewise linear penalty was imposed  on the computed values of each NTCP, 
minor importance was paid to small NTCP and only a small penalty to the score is assessed. 
We proposed a new objective function based on the NTCP criteria and TCP criteria during the 
high temperature stage, to improve the global optimization ability of simulated annealing by 
increasing poor solutions acceptance rate, while the same objective function proposed by 
Mohan et al [6] was used for low temperature stage. The effectiveness of the proposed method 
was assessed in 10 prostate cancer cases, and compared with optimization method proposed 
by Mohan et al [6]. 
 
 
2. Methods and Materials 
 
2.1. Simulated Annealing Optimization Algorithm 
The simulated annealing method (SA) is derived from thermodynamics and has a 
unique potential for finding the global minimum. It is well suited for optimization problems 
involving a large number of variables. The essence of the algorithm is as follows: in each step of 
an iterative procedure the parameter values (i.e., beam weights) are randomly changed, where 
the random changes are sampled from a distribution. Then the resulting change ΔF  in the 
objective function is calculated. If the function decrease, the change is always accepted; 
otherwise it is randomly accepted with a probability given by the Boltzmann distribution
F)/kT](exp[p  , where k is the Boltzmann constant (Mohan et al 1992), and that is the 
Metropolis criteria. The Metropolis criteria can be defined as follows: 
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Where the parameter T regulates the rate at which the optimization occurs and is 
analogous to the temperature in the annealing process, and the function of rand randomly 
generates the number located between [0, 1). 
The details of the SA algorithm were described in Mohan et al [6]. 
 
2.2. Dose Calculations 
The standard pencil beam model proposed by Ahnesjö [21] was applied to calculate 
dose distributions. The total dose Di to a voxel i can be calculated as: 
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Where wij, the so-called dose depositon coefficient, represent the dose received by the 
voxel i from the beamlet j of unit intensity. The number of beamlets is denoted by Nb and the 
intensity of beamlets is xj,j=1,2…,Nb. NT is the total number of voxels in optimized tissues. The 
dose distributions could be expressed in a matrix-vector form as  
 
 WxxD )(          (3) 
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Where D(x) is the dose distribution vector (dose for each patient voxel), W is the dose 
calculation matrix, and x is the fluence elements (beamlet weights). 
 
2.3. Clinical and Biological Models 
(1) Tumor Control Probability (TCP): TCP is the probability of the elimination of tumor 
cells, not only related to the changes in the dose, but related to the tumor size, cell oxygen 
status and other factors. Some domestic and foreign scholars have made some TCP models 
based on the same assumption that the tumor is composed of some independent clonal cells, 
and these clones are independent of the reaction. 
In our work, we implemented the logistic function proposed by Schultheiss [18].The 
TCP in the form of a logistic function is expressed as  
 
 kDD
DTCP
)/(1
1)(
50
         (4) 
 
Where D50 is the dose required to achieve a 50% probability of control and k is a 
measure of the slope of the dose response curve. 
(2) Normal Tissue Complication Probability (NTCP): NTCP is the probability that the 
organ or tissue damage after radiation therapy, it is also associated with the volume of the 
normal tissue to receive irradiation. The NTCP model we applied was the LKB [22, 23] model, 
defined by 
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  is the standard normal cumulative 
distribution function; D50 represents the tolerance dose to a whole organ, causing a 50% 
complication probability; m is the slope of the sigmoidal function Φ; and gEUD(D(x)) is the 
generalized equivalent uniform dose of the dose distribution D(x), given by 
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N is the number of voxels in the anatomic structure of interest, Di is the dose in the ith 
voxel, and a is the tissue-dependence parameter that represents the dose-volume effect. The 
gEUD model can be applied to both tumor area and normal tissue. 
 
2.4. The Objective Function 
We adopted the model proposed by Mohan et al for combing the TCP and NTCPs into 
a single score represented as: 
 
  i itc sPF          (7) 
 
Where si is component scores for each normal structure, Ptc is the TCP calculated by 
formula (4). 
To improve the global optimization ability of simulated annealing by increasing poor 
solutions acceptance rate, we proposed a new objective function based on the NTCP criteria 
and TCP criteria during the high temperature stage, while the same objective function named 
piecewise linear penalty function proposed by Mohan et al [6] was used for low temperature 
stage. Figure 1 provides a broad overview of the method. 
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Figure 1. Broad overview of the method 
 
 
The operations in dotted-lined rectangle in figure 1 are the differences between our 
method and the method proposed by Mohan et al’s [6]. Here we first judge the current 
temperature T is high or low temperature stage, if it is high temperature stage, calculating the 
function value according to equation (9) described below, or else calculating defined in equation 
(8) below. In our experiments, we defined 0T32T   as high temperature, which was determined 
by trial and error method. 
(1) Piecewise linear penalty function: At low temperature stage, the si in equation (7) 
are given by 
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Where Pa is an acceptable level for each organ, sa is the score corresponding to the 
acceptable NTCP, and Pc is a defined critical level above which the treatment plan score 
becomes zero. In our work, we set 5.0,05.0  ca PP . 
(2) New objective function: At high temperature stage, the si in equation (7) are given by 
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The relative relationship between the piecewise linear penalty and the new objective 
function described by formulas (8) and (9) was shown in figure 2. 
For piecewise linear penalty function ,we can see that as long as the NTCP remains 
below Pa, minor importance was assigned to it and only a small penalty to the score is 
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assessed; when cntca PPP  , more importance was assigned to it and more penalty to the 
score is assessed; when ntcc PP   the plan score becomes zero. But in the new objective 
function, the bigger Pntc the less importance was assigned to it and fewer penalties to the score 
is assessed. According to Metropolis criteria, we can know that for the new state, corresponding 
to ΔF , the acceptance rate of the state located in (0, Pa) is greater than the state located in (Pa, 
Pc) in piecewise linear penalty function. However, the poorer the new state is, the higher the 
acceptance rate is in our proposed new objective function, since the slope of the curve becomes 
smaller along with the increasing Pntc. To improve the global optimization ability of simulated 
annealing, at high temperature stage we applied the new objective function, and at low 
temperature stage piecewise linear penalty function was applied.  
 
 
 
 
Figure 2. NTCP penalty function 
 
 
3. Results  
 
3.1. Experimental Parameters Setting 
The effectiveness of the proposed method was assessed in 10 prostate cancer cases, 
and was compared with optimization method using piecewise linear penalty function. For the 
sake of simplicity, we randomly chose the experimental results of one patient to show the 
differences. All plans used identical configurations of five coplanar 6MV photon beams, with 
gantry angles of 36, 100, 180, 260 and 324 (IEC Convention). For optimization of treatment 
plans, parameters for the computation of the NTCPs for rectum and bladder were obtained from 
Emami et al [24] and Kutcher et al [25] shown in Table 1. 
To evaluate two different treatment plans, we used dose volume histogram (DVH), dose 
(maximum dose, minimum dose, mean dose), and biological indices (gEUD, TCP, NTCP) to 
comparisons. 
 
 
Table 1. Parameters used for calculating TCP and NTCPs 
Target (prostate） k=50 D50=76.8Gy - 
rectum m=0.15 n=0.12 D50=78Gy 
bladder m=0.15 n=0.12 D50=79Gy 
 
 
3.2. Comparisons of DVH 
DVH curve was defined as the volume received dose over Dmax is not more than Vmax%, 
is a kind of commonly used radiotherapy planning evaluation tool, it can be used to evaluate the 
uniformity of the target area, but also can be used to reflect the normal tissue and the dose to 
the organ. Two different sets of DVH curves obtained from two different optimization methods 
are shown in figure 3. The solid lines and dotted line represent the plans based on new 
proposed function and piecewise linear penalty function respectively. It can be seen that the 
new plan is much better than piecewise linear penalty function based plan in terms of PTV 
coverage and OARs sparing. In particular, the PTV receive more uniform dose and less high 
dose, i.e. the volume received dose 90Gy decrease from 32% to 14%. The rectum is better 
                     ISSN: 1693-6930 
TELKOMNIKA Vol. 14, No. 2A, June 2016 : 379 – 387 
384
spared. For example, the fractional volume of the rectum that receives a dose above 50Gy is 
dropped from 45% to 37%.  
 
3.3. Dose Comparisons 
Dose comparisons in terms of Dmax、Dmin and Dmean were done for both PTV and OARs, 
as shown in table 2. It is clearly seen that the dose distributions of irradiated tissues were 
improved to different degrees. For example, the maximum dose to PTV, rectum and bladder 
dropped 2.7%, 3.99% and 2.84% respectively. 
 
 
 
 
 
 
Figure 3. The whole and high dose volume histograms for PTV (a), rectum wall (b), and bladder 
wall (c). The solid lines represent the DVH curves of new proposed optimization, and the dotted 
line the DVH curves of the piecewise linear penalty function based optimization 
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Table 2. Dose for PTV, rectum and bladder 
organ 
New function (Gy) Piecewise linear penalty function (Gy) 
Dmax Dmin Dmean Dmax Dmin Dmean 
PTV 104.87 69.525 82.71 107.78 70.43 86.63 
rectum 81.97 - 40.20 84.93 - 42.25 
bladder 82.52 - 14.39 85.38 - 14.61 
 
 
3.4. Comparisons of Biological Indices 
The biological indices results of our new method showed the lower gEUD and NTCP 
values for both the rectum and bladder walls, as shown in table 3. The parameter a=8, 8, -10 
were respectively applied in the gEUD calculations of rectum, bladder and PTV. We used the 
same TCP, NTCP models and parameters as those used by Mohan et al [6] to calculate the 
TCP and NTCP values. The rate of change was defined as 
 
 
( ) -( )
( )
new piecewise
piecewise
value value
rate of change
value
       (10) 
 
It is clearly shown that the biological indices of new plan based on new method 
optimization are better than that gained based on piecewise linear penalty function optimization. 
The NTCP values of rectum and bladder dropped 11.71% and 28.75% respectively, the TCP 
value is similar, and therapeutic gain ratio is increased. For different optimization tissues, gEUD 
has been improved to different degrees shown in table 3. 
 
 
Table 3. TCP, NTCP values 
functions 
rectum bladder PTV 
NTCP gEUD NTCP gEUD TCP gEUD 
New function 2.94% 61.16 7.51% 83.48 95.65% 57.60 
Piecewise linear penalty function 3.33% 63.36 10.54% 83.60 95.60% 57.26 
Rate of change -11.7% -3.47% -28.8% -0.14% 0.05% 0.59% 
 
 
4. Discussion 
The ultimate goal of radiotherapy treatment planning is to find a treatment that will yield 
a high tumor control probability (TCP) with an acceptable normal tissue complication probability 
(NTCP). Yet most treatment planning today is not based upon optimization of TCPs and NTCPs 
because of uncertainties associated with the models, but rather upon meeting physical dose 
and volume constraints defined by the planner. It has been suggested that treatment planning 
evaluation and optimization would be more effective if they were biologically and not 
dose/volume based [26]. 
In our work, the essence of the new inverse planning approach presented here is the 
combination of clinically relevant optimization and simulated annealing optimization algorithm in 
a large-scale unconstrained optimization model. To improve the global optimization ability of 
simulated annealing by increasing poor solutions acceptance rate, we adopted different 
optimization model for different optimization stage as described above. To verify the 
effectiveness of the proposed method, experiments were conducted involving 10 prostate 
cancer cases, and compared with the work done by Mohan et al. The results shown in figure 3, 
table 2 and table 3 indicated that the new plan generated by our proposed optimization method 
was better than the plan based on Mohan et al’s optimization method in terms of PTV coverage 
and OARs sparing. The improvements attributed to the increase of poor solutions acceptance 
rate at high temperature stage of SA by the slope change of the optimization function depicted 
in figure 2. 
This work is meaningful for the study of biological optimization in radiotherapy research. 
There are still some challenges for improvement. First, the boundary between the high 
temperature stage and the low temperature stage is not easily defined. In our experiments, we 
determined it by trial and error method, that is, we defined the temperature, which was higher 
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than two-thirds of initial temperature T0 as high temperature. The boundary directly affects the 
optimization results. Second, as can be seen from the DVHs in figure 3, the plans based in 
clinically relevant optimization provides less control of the high-dose distribution in the PTV 
compared with dose or dose-volume based plans [9], since a biologically based cost function 
would not be sensitive hot spots inside the target as these hot spots could increase tumor-cell 
killing[10]. More studies are needed for improve the quality of treatment plan based on biological 
relevant optimization. 
 
 
5. Conclusions 
In the work, we proposed biological relevant indices based a new optimization method, 
consisting of controlling the dose delivered to normal tissues and target by NTCP-based sub-
scores and TCP-based sub-score respectively. The large-scale optimization problem was then 
solved by means of SA algorithm, and the strategy of increasing the poor solutions acceptance 
rate was added to improve the global optimization ability of SA. The proposed method was 
applied in 10 prostate cancers. Our method was proven that our method can generate better 
radiotherapy plans than plans attained by applying the commonly used SA algorithm. 
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